Teva's Biosimilar Boom Just Beginnings: Is It Time to Buy?
Teva is turning the corner with a growing biosimilars roster and improving margins. This article examines whether tev...
This guide explains how to identify price-weighted indexes and what characteristics indicate a price-based method.
25,721 articlesTeva is turning the corner with a growing biosimilars roster and improving margins. This article examines whether tev...
AI demand has sparked a rapid rally in memory stocks, but signs of inventory normalization and pricing pressure pose ...
SOL and HYPE lead a weekend rally as Bitcoin reclaimes the 63K level, with ZEC and select alts posting fresh gains am...
A rare fraud case shows how fake test samples led to millions in payments. Learn how it happened, what it means for y...
Opendoor and Offerpad led a narrow iBuyer rally with midday gains of about 7% and 6%, respectively. The move comes as...
At a pivotal AI summit, the UN chief framed AI risks in a way that resonates with crypto stakeholders. This article t...
A $1,000 invest? here’s what XRP and Bitcoin could be worth by 2027, depending on regulatory outcomes for XRP and mac...
Maestro has gone live on Robinhood Chain, bringing its Telegram-first trading bot to a fast-moving Arbitrum layer-2. ...
Ethereum faces a tricky moment as analysts flag a bullish flag in a chart that’s inverted, signaling potential big mo...
IonQ is set to report Q4 2025 earnings tonight, confronting a valuation that many analysts say risks outpacing the co...
As accel acel 2025 earnings loom, investors seek clarity on revenue, margins, and guidance. This guide breaks down wh...
Three consumer-facing stocks — Planet Fitness, Brown-Forman, and Campbell’s — moved on earnings, tariffs, and margin ...